Data as of Apr 17
| +2.46 / +1.87%|
The 20 analysts offering 12-month price forecasts for Allergan Inc have a median target of 135.00, with a high estimate of 150.00 and a low estimate of 109.00. The median estimate represents a +0.81% increase from the last price of 133.92.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.